Log In
Print
BCIQ
Print
Print this Print this
 

ATSP-9172

  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionStapled peptide inhibitor of hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionHypoxia-inducible factor 1 (HIF1) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today